Clin2
NCT07557537Possibly a fitNot yet recruiting

Safety study of KHN707 tablets in healthy volunteers

Healthy Adult Participants

This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
38 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are in good general health, with no major medical conditions.
  • You have a body mass index (BMI) between 19 and 26.
  • You are willing to use effective birth control and not donate sperm or eggs for a few months.
  • You have not used certain medicines, supplements, or received vaccines recently.
  • You can follow the study rules, like avoiding alcohol, caffeine, smoking, and strenuous exercise during the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07044960Not yet recruiting· Phase 1
Study of KHN702 tablets in healthy volunteers

This study tests a new medicine called KHN702 in healthy volunteers to see how the body processes it and whether it is safe. It is an early-stage trial, so participants will help find out how the drug works before it is studied in patients.

NCT07521345Recruiting· Phase 1
Safety Study of HSK55879 Tablet in Healthy Adults

This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.

Hefei, Anhui
NCT07412288Recruiting· Phase 1
Safety study of KT-579 in healthy volunteers

This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.

Lincoln, Nebraska
NCT07314541Recruiting· Phase 1
KMY Tablets Safety Study in Healthy Adults

This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.

Suzhou, Jiangsu
NCT07647783Recruiting· Phase 1
Safety Study of SYH2072 Tablet in Healthy Adults

This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.

Beijing, Beijing Municipality
NCT06867393Recruiting· Phase 1
Safety study of HL-003 in healthy volunteers

This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.

Suzhou, Jiangsu

Hear when a new Healthy Adult Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.